The Changing Face of NAMI

54
Pete Early, author of Crazy, traces the history of NAMI, including its "complicated love-hate relationship with Dr. E. Fuller Torrey" and shift from his...

J&J Settlement Inspires PA Legislators on False Claims Act

4
Following Johnson & Johnson's $2.2 billion settlement for off-label marketing and kickbacks related to its antipsychotic Risperdal, Pennsylvania legislators Brandon Neuman and Tony DeLuca...

In Ireland, Antipsychotic Drugs Used Extensively On People With Learning Disabilities

8
Over half of people with learning disabilities living in residential centers in Ireland are being prescribed antipsychotics.

Antidepressants During Pregnancy Do Not Appear To Reduce Relapses And Hospitalizations

5
Continuing to take antidepressants during pregnancy was associated with higher rates of depressive relapses and hospitalizations than discontinuing.

Increased Risk of Heart Defects with SSRIs

1
Danish research found a significantly increased risk of congenital heart defects in both the 4,183 pregnancies exposed to SSRIs throughout the first trimester and the...

J&J Takes Last Stab at $1.2B Risperdal Verdict

5
Lawyers for Johnson & Johnson took the stand in Arkansas today, a final effort at convincing the Arkansas Supreme Court to overturn a jury's...

Drug Detailing More Influential than FDA Approval

2
FDA approvals are less influential on prescribing patterns than pharmaceutical sales marketers are, according to a study in Health Affairs. University of California and...

Despite Official Recommendations, Young Children Are Still Receiving Drugs Instead of Therapy for ‘ADHD’

6
In 2011 the American Academy of Pediatrics (AAP) issued guidelines recommending therapy over stimulant drugs as the primary treatment for children diagnosed with ‘ADHD.’ New research from the CDC reveals, however, that children between ages 2 and 5 are still being prescribed medications before receiving the recommended therapy or psychological services. Overall, the researchers found that 75% of these children are being prescribed “ADHD’ drugs while no more than 55% receive psychological treatments. Incredibly, among children on private insurances, the percentage of children receiving psychological services for ‘ADHD’ showed no increase following the 2011 recommendations.

Psychotropics Significantly Increase Falls in the Elderly

1
Psychotropic medications, including short-acting benzodiazepines, strongly increase the frequency of falls in the elderly, according to research from the Netherlands published in Maturitas: The...

How Does the News Cover Mental Health Issues?

11
The news media frequently write stories that connect mental health issues with violence, according to a new study published this month in Health Affairs....

Ohio to Review Antipsychotics in Foster and Other Children

0
The state of Ohio plans to invest $1 million in the next three years to review the use of psychiatric drugs prescribed to children,...

Serious Warnings on Drugs Paradoxically Increase Sales

0
Researchers from Tel Aviv, Singapore and New York find that  although "Warnings that a promoted product can have adverse side effects (e.g., smoking cigarettes...

Community-Based Treatment Beats Facilities in Low-Income Country Schizophrenia Study

1
Treatment by lay health workers is more effective than standard facility-based care at reducing disability and psychotic symptoms in people with schizophrenia diagnoses, according...

Report on University of Minnesota Psychiatric Research Practices “Scathing”

1
The latest investigative report into the University of Minnesota's psychiatric research practices was "scathing," reported Forbes in a two-part story.

Are Antidepressants and Psychotherapy Really Equally Effective for Depression?

27
A recent review of the evidence by the American College of Physicians (ACP) determined that cognitive behavioral therapy and antidepressants had similar levels of effectiveness for the treatment of depression. In a critical commentary for the Journal of Mental Health, however, Michael Sugarman from Wayne State University challenges these findings. Pointing to differences in research settings and clinical practice, Sugarman asserts that “these head-to-head comparisons are heavily biased in the direction of psychiatric care.”

Happiness and First-Episode Schizophrenia

7
Canadian researchers find that 31 people with first-episode schizophrenia diagnoses were as happy as 29 controls, according to a self-reported questionnaire measuring happiness, life...

Antidepressants Linked to Heart Arrhythmias

0
Researchers from the Mass General and Brigham & Women's Hospitals and the Mt. Sinai School of Medicine find, using data from electronic health records...

2nd-Generation Antipsychotics Cause Extrapyramidal Side Effects as Much as 1st-Generation

7
According to researchers from Yale and the U.K., the improvements in extrapyramidal side effects expected from 2nd-generation antipsychotics has not been realized, while the...

Pentagon Was Warned Off Antipsychotic for PTSD

1
Despite 2004 clinical guidelines issued by the Veterans' Administration that "there is insufficient evidence to recommend atypical antipsychotics for the treatment of PTSD,"  ...

“A Glut of Antidepressants”

10
The New York Times reflects on various explanations for the skyrocketing use of antidepressants (the economy, pharmaceutical advertising, the effect of insurance), then reports...

Consumer Reports: Antipsychotics in Children Rises Despite Questions of Safety & Efficacy

9
Consumer Reports writes that the number of children prescribed antipsychotics has tripled over the last 10 to 15 years, despite a lack of evidence...

Stimulants, But Not Cannabis, Predict Readmission for Psychosis

1
Prior admissions with stimulant disorder, but not a prior cannabis disorder diagnosis, are a negative prognostic sign in first-episode psychosis according to new research...

New York Times Issues Correction on RAISE Study Report

6
Last Tuesday, The New York Times and several other outlets (including Mad In America) reported on the highly-touted results of a study on psychosocial treatment for patients diagnosed with schizophrenia. Now, claims made about the study, which the ‘Times called “the most rigorous trial to date,” are coming under increased scrutiny.

Measuring How Mental Health Professionals See Service Users’ Rights

20
A new scale has been developed and validated to examine beliefs held by mental health professionals towards service users’ rights.

Outcome of Mood Disorders Before Psychopharmacology

1
A "systematic review" of all outcome studies of patients with mood disorders, in the March issue of the Australia & New Zealand Journal of...